Day One Biopharmaceuticals Inc
NASDAQ:DAWN 4:00:00 PM EDT
| Market Cap (Intraday) | 1.19B |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $13.86 |
| 50-Day MA | $13.92 |
| 200-Day MA | $14.60 |
Day One Biopharmaceuticals Inc Stock, NASDAQ:DAWN
2000 Sierra Point Parkway, Suite 501, Brisbane, California 94005
United States of America
Phone: +1.650.484.0899
Number of Employees: 155
Description
Day One Biopharmaceuticals, Inc. operates as a holding company. The firm through its subsidiary develops and commercializes targeted therapies for patients of all ages with genetically defined cancers. Its products include DAY101 and pimsertib. The company was founded by Julie Grant and Samuel Blackman in November 2018 and is headquartered in Brisbane, CA.